Bromide

Bromide

SCHEMBL811908

Br.c1ccc(Cn2ccnc2-c2ccccc2)cc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.60
LIMK2 P53671 1/20 0.60
BRD4 O60885 3/20 0.58
ESR1 P03372 1/20 0.55
PDE6D O43924 1/20 0.49
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX12 P18054 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
PLAA Q9Y263 1/20 0.46
CYP19A1 P11511 1/20 0.46
HSP90AA1 P07900 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17621 0.98 HSD17B10 (0.62) HSD17B10LIMK2BRD4ESR1PDE6D
Iodide SCHEMBL28519464 0.96 HSD17B10 (0.60) HSD17B10LIMK2BRD4ESR1PDE6D
Fluoride SCHEMBL10339918 0.96 HSD17B10 (0.60) HSD17B10LIMK2BRD4ESR1PDE6D
Hydrochloric Acid SCHEMBL233781 0.96 HSD17B10 (0.60) HSD17B10LIMK2BRD4ESR1PDE6D
Fluoride Ion SCHEMBL10906965 0.95 LIMK2 (0.59) HSD17B10LIMK2BRD4ESR1PDE6D
SCHEMBL5981532 0.95 LIMK2 (0.63) HSD17B10LIMK2BRD4ESR1PDE6D
Fluoride SCHEMBL10906966 0.95 LIMK2 (0.59) HSD17B10LIMK2BRD4ESR1PDE6D
Bromide SCHEMBL811907 0.95 LIMK2 (0.59) HSD17B10LIMK2BRD4ESR1PDE6D
SCHEMBL10906967 0.92 LIMK2 (0.56) HSD17B10LIMK2BRD4ESR1PDE6D
SCHEMBL2840217 0.90 LIMK2 (0.58) HSD17B10LIMK2BRD4ESR1PDE6D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119307169-A Curable composition, cured product, overcoat film for flexible wiring board, and method for producing flexible wiring board 日保丽公司 2025-01-14 CN disclosed
EP-3395848-B1 POLYURETHANE, CURABLE COMPOSITION, OVERCOAT FILM, AND FLEXIBLE WIRING BOARD AND PRODUCTION METHOD THEREFORE NIPPON POLYTECH CORP (JP) 2024-02-28 EP disclosed
EP-2977406-B1 CURABLE COMPOSITION LG CHEMICAL LTD (KR) 2024-01-24 EP disclosed
CN-114080408-B Cured product, overcoat film, and flexible wiring board 日保丽公司 2023-08-25 CN disclosed
CN-114096579-B Polyurethane and curable composition 日保丽公司 2023-06-09 CN disclosed
CN-114096579-A Polyurethane and curable composition 日保丽公司 2022-02-25 CN disclosed
CN-114080408-A Cured product, overcoat film, and flexible wiring board 日保丽公司 2022-02-22 CN disclosed
CN-114072444-A Curable composition, cured product, overcoat film, flexible wiring board, and method for producing same 日保丽公司 2022-02-18 CN disclosed
CN-109071954-B Curable composition, cured film using same, and overcoat film 日保丽公司 2021-11-02 CN disclosed
CN-109071955-B Curable composition, cured film using same, and overcoat film 日保丽公司 2021-10-15 CN disclosed
CN-102272186-A (Poly)carbonate polyol and carboxyl group-containing polyurethane using the (poly)carbonate polyol as starting material 2011-12-07 CN disclosed
CN-102272185-A Carboxyl group-containing polyurethane 2011-12-07 CN disclosed
EP-2390276-A1 CARBOXYL GROUP-CONTAINING POLYURETHANE Showa Denko K.K. (JP) 2011-11-30 EP disclosed
EP-2390277-A1 (POLY)CARBONATE POLYOL AND CARBOXYL GROUP-CONTAINING POLYURETHANE USING THE (POLY)CARBONATE POLYOL AS STARTING MATERIAL Showa Denko K.K. (JP) 2011-11-30 EP disclosed
CN-102264838-A Curable composition 2011-11-30 CN disclosed
US-20110272182-A1 CARBOXYL GROUP-CONTAINING POLYURETHANE SHOWA DENKO K.K. (JP) 2011-11-10 US disclosed
US-20110272183-A1 (POLY)CARBONATE POLYOL AND CARBOXYL GROUP-CONTAINING POLYURETHANE OBTAINED FROM THE (POLY)CARBONATE POLYOL SHOWA DENKO K.K. (JP) 2011-11-10 US disclosed
EP-2383310-A1 CURABLE COMPOSITION Showa Denko K.K. (JP) 2011-11-02 EP disclosed
US-20110257257-A1 COMPOSITION FOR TREATMENT OF EPITHELIAL TISSUE NOVODERMIX INTERNATIONAL LIMITED (VG) 2011-10-20 US disclosed
US-20110253426-A1 CURABLE COMPOSITION SHOWA DENKO K.K. (JP) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110272183-A1 (POLY)CARBONATE POLYOL AND CARBOXYL GROUP-CONTAINING POLYURETHANE OBTAINED FROM THE (POLY)CARBONATE POLYOL PUF60, PARG, PIK3C2G HSD17B10 895/4885LIMK2 230/4885BRD4 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.